Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality

Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

The Oresund region aims at becoming Europe’s microbiome Mecca

The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.

Automated opening and closing of sample vials

From technical requirements to a suitable solution

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Nya Alzheimerdata från konkurrent fick Bioarctics aktie att backa

Det svenska forskningsbolaget Bioarctic, utvecklaren bakom Alzheimersläkemedlet Leqembi (lecanemab), handlades nedåt på börsen på onsdagen efter att amerikanska...

ALS – When the body has given up, but the brain persists

The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network ...

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

"Imponerande kraftsamling gav vaccin"

Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Bioarctics Alzheimerläkemedel godkänt i USA

Alzheimerläkemedlet lecanemab godkänns i USA. Beskedet på fredagen är en fullträff för svenska Bioarctic som stått för den tidiga utvecklingen av preparatet.

Uppåt för Bioarctic efter positivt USA-besked

Bioarctics aktie steg kraftigt när börsen öppnade på måndagen för första gången efter godkännandet i USA för bolagets Alzheimerläkemedel lecanemab.

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Blodtest från Roche ska ge tidig Alzheimersdiagnos

Det schweiziska läkemedels- och diagnostikbolaget Roche har tagit fram ett blodtest som ska underlätta diagnostiken inom Alzheimers sjukdom.

Positiva FDA-signaler om Bioarctics Alzheimerläkemedel

Dokument från den amerikanska läkemedelsmyndigheten FDA släppta inför ett panelmöte på fredag om Eisais och Bioartics Alzheimerbehandling Leqembi (lecanemab) hö...

"Sjukdomsmodifiering blir standard i Alzheimers"

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Viss effekt av Alzheimers-behandling bekräftas i studie – Bioarctic stiger på börsen

Nya data bekräftar att Bioarctics läkemedel lecanemab bromsar Alzheimers sjukdom – om än i måttlig utsträckning och med vissa biverkningar. Beskedet fick bolage...